Juno Therapeutics, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Juno Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Juno Therapeutics, Inc. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.55 | 4,157 | 355,631 | 89,614 | 93.8 K to 89.6 K (-4.43 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Harr Steve | CFO & Head, Corp. D ... | Gift | G | 0.00 | 162,790 | 0 | 627,973 | 790.8 K to 628 K (-20.59 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Harr Steve | CFO & Head, Corp. D ... | Payment of Exercise | F | 85.49 | 1,704 | 145,675 | 790,763 | 792.5 K to 790.8 K (-0.22 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel & S ... | Gift | G | 0.00 | 26,634 | 0 | 85,262 | 111.9 K to 85.3 K (-23.80 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel & S ... | Payment of Exercise | F | 85.49 | 1,528 | 130,629 | 111,896 | 113.4 K to 111.9 K (-1.35 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Gift | G | 0.00 | 116,280 | 0 | 2,448,229 | 2.6 M to 2.4 M (-4.53 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Payment of Exercise | F | 85.49 | 4,346 | 371,540 | 2,564,509 | 2.6 M to 2.6 M (-0.17 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 20.76 | 2,663 | 55,284 | 98,545 | |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 25.29 | 834 | 21,092 | 30,002 | |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.77 | 3,497 | 299,938 | 93,771 | 97.3 K to 93.8 K (-3.60 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 20.76 | 2,663 | 55,284 | 97,268 | 94.6 K to 97.3 K (+2.81 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 25.29 | 834 | 21,092 | 94,605 | 93.8 K to 94.6 K (+0.89 %) |
| Feb 09 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Payment of Exercise | F | 85.49 | 2,700 | 230,823 | 93,771 | 96.5 K to 93.8 K (-2.80 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | LEE ANN L. | EVP, Technical Oper ... | Grant | A | 0.00 | 40,788 | 0 | 110,792 | 70 K to 110.8 K (+58.27 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Harr Steve | CFO & Head, Corp. D ... | Grant | A | 0.00 | 29,135 | 0 | 792,467 | 763.3 K to 792.5 K (+3.82 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Cassidy Bernard J | General Counsel & S ... | Grant | A | 0.00 | 25,639 | 0 | 113,424 | 87.8 K to 113.4 K (+29.21 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Bishop Hans Edgar | CEO & President | Grant | A | 0.00 | 66,426 | 0 | 2,568,855 | 2.5 M to 2.6 M (+2.65 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Option Exercise | M | 51.76 | 4,167 | 215,684 | 93,294 | |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Sell | S | 85.78 | 4,167 | 357,445 | 96,471 | 100.6 K to 96.5 K (-4.14 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Buy | M | 51.76 | 4,167 | 215,684 | 100,638 | 96.5 K to 100.6 K (+4.32 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | Azelby Robert | EVP & Chief Commerc ... | Grant | A | 0.00 | 25,639 | 0 | 96,471 | 70.8 K to 96.5 K (+36.20 %) |
| Feb 02 2018 | JUNO | Juno Therapeutics, ... | AGARWAL SUNIL | President of R & D | Grant | A | 0.00 | 29,135 | 0 | 149,577 | 120.4 K to 149.6 K (+24.19 %) |